Effect of inhaled natural interferon-alpha on diffuse bronchioalveolar carcinoma.
Six patients with diffuse bronchioalveolar carcinoma confined to the thorax were treated with interferon-alpha by inhalation. The dose was 1 or 6 MU thrice daily. Therapy was continued until the tumour progressed or bronchial hyperreactivity became unacceptable. The treatment was not effective.
Kinnula
V
V
Department of Pulmonary Medicine, Helsinki University Central Hospital, Finland.
Cantell
K
K
Mattson
K
K
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000628:therapy*; D000280:Administration, Inhalation; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers
D007370:Interferon Type I